IMA Advisory Services, Inc.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1455495
DENVER, CO
Position in REGN
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$1,647,268
-$10,708 QoQ
Shares Held
2,132
-0.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026IMA Advisory Services, Inc. holds $5,734,538 across 18 Biotechnology names. REGN ranks #2 (28.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
94,710 | $4,062,111 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
2,132 | $1,647,268 | |
| 3 | INCY |
Incyte Corp
|
43 | $4,047 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
52 | $2,937 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
10 | $2,583 | |
| 6 | MRNA |
Moderna, Inc.
|
45 | $2,286 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
28 | $2,102 | |
| 8 | INSM |
INSMED Inc
|
12 | $1,962 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,647,268 | 2,132 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,657,976 | 2,148 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,220,688 | 2,171 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,156,050 | 2,202 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,270,362 | 2,003 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,639,783 | 2,302 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,444,133 | 2,325 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,855,648 | 2,717 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $2,672,834 | 2,777 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $2,605,886 | 2,967 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $2,705,069 | 3,287 | Shares | Sole | 2023-11-28 | |
| 2023-06-30 | $2,393,456 | 3,331 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $2,718,906 | 3,309 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $2,535,315 | 3,514 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $2,503,353 | 3,634 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $2,320,776 | 3,926 | Shares | Sole | 2022-08-18 | |
| 2022-03-31 | $2,953,618 | 4,229 | Shares | Sole | 2022-06-13 | |
| 2021-12-31 | $2,747,743 | 4,351 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,787,459 | 4,606 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $2,364,299 | 4,233 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,550,479 | 3,277 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,472,036 | 3,047 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,927,322 | 3,443 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,146,603 | 3,442 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,693,389 | 3,468 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||